Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Aberrant expression of the PRAC gene in prostate cancer.

Lenka G, Weng WH, Chuang CK, Ng KF, Pang ST.

Int J Oncol. 2013 Dec;43(6):1960-6. doi: 10.3892/ijo.2013.2117. Epub 2013 Oct 2.

PMID:
24100630
[PubMed - indexed for MEDLINE]
2.

Progression to metastatic stage in a cellular model of prostate cancer is associated with methylation of the androgen receptor gene and transcriptional suppression of the insulin-like growth factor-I receptor gene.

Schayek H, Bentov I, Sun S, Plymate SR, Werner H.

Exp Cell Res. 2010 May 15;316(9):1479-88. doi: 10.1016/j.yexcr.2010.03.007. Epub 2010 Mar 23.

PMID:
20338164
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Combination of resveratrol and antiandrogen flutamide has synergistic effect on androgen receptor inhibition in prostate cancer cells.

Kai L, Levenson AS.

Anticancer Res. 2011 Oct;31(10):3323-30.

PMID:
21965742
[PubMed - indexed for MEDLINE]
4.

Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis.

Tian J, Lee SO, Liang L, Luo J, Huang CK, Li L, Niu Y, Chang C.

J Biol Chem. 2012 Nov 16;287(47):39954-66. doi: 10.1074/jbc.M112.395574. Epub 2012 Sep 25.

PMID:
23012352
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

PRAC: A novel small nuclear protein that is specifically expressed in human prostate and colon.

Liu XF, Olsson P, Wolfgang CD, Bera TK, Duray P, Lee B, Pastan I.

Prostate. 2001 May 1;47(2):125-31.

PMID:
11340635
[PubMed - indexed for MEDLINE]
6.

Characterization of androgen regulation of ZEB-1 and PSA in 22RV1 prostate cancer cells.

Anose BM, LaGoo L, Schwendinger J.

Adv Exp Med Biol. 2008;617:541-6. doi: 10.1007/978-0-387-69080-3_55.

PMID:
18497080
[PubMed - indexed for MEDLINE]
7.

Identification of novel androgen receptor target genes in prostate cancer.

Jariwala U, Prescott J, Jia L, Barski A, Pregizer S, Cogan JP, Arasheben A, Tilley WD, Scher HI, Gerald WL, Buchanan G, Coetzee GA, Frenkel B.

Mol Cancer. 2007 Jun 6;6:39.

PMID:
17553165
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells.

Gravina GL, Festuccia C, Millimaggi D, Dolo V, Tombolini V, de Vito M, Vicentini C, Bologna M.

Prostate. 2008 May 15;68(7):793-801. doi: 10.1002/pros.20748.

PMID:
18324645
[PubMed - indexed for MEDLINE]
9.

Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia.

Zhong W, Peng J, He H, Wu D, Han Z, Bi X, Dai Q.

Clin Invest Med. 2008;31(1):E8-E15.

PMID:
18312749
[PubMed - indexed for MEDLINE]
10.

Quantitative assessment of AKAP12 promoter methylation in human prostate cancer using methylation-sensitive high-resolution melting: correlation with Gleason score.

Liu W, Gong J, Hu J, Hu T, Sun Y, Du J, Sun C, Guan M, Jiang H, Lu Y.

Urology. 2011 Apr;77(4):1006.e1-7. doi: 10.1016/j.urology.2010.12.010. Epub 2011 Feb 18.

PMID:
21310466
[PubMed - indexed for MEDLINE]
11.

EFEMP1 as a novel DNA methylation marker for prostate cancer: array-based DNA methylation and expression profiling.

Kim YJ, Yoon HY, Kim SK, Kim YW, Kim EJ, Kim IY, Kim WJ.

Clin Cancer Res. 2011 Jul 1;17(13):4523-30. doi: 10.1158/1078-0432.CCR-10-2817. Epub 2011 May 13.

PMID:
21571867
[PubMed - indexed for MEDLINE]
Free Article
12.

Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.

Iwasa Y, Mizokami A, Miwa S, Koshida K, Namiki M.

Int J Urol. 2007 Mar;14(3):233-9.

PMID:
17430262
[PubMed - indexed for MEDLINE]
13.

Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.

Denmeade SR, Sokoll LJ, Dalrymple S, Rosen DM, Gady AM, Bruzek D, Ricklis RM, Isaacs JT.

Prostate. 2003 Mar 1;54(4):249-57.

PMID:
12539223
[PubMed - indexed for MEDLINE]
14.

Androgen-induced prostate-specific antigen gene expression is mediated via dihydrotestosterone in LNCaP cells.

Zhu YS, Cai LQ, You X, Cordero JJ, Huang Y, Imperato-McGinley J.

J Androl. 2003 Sep-Oct;24(5):681-7.

PMID:
12954658
[PubMed - indexed for MEDLINE]
15.

Differentially expressed androgen-regulated genes in androgen-sensitive tissues reveal potential biomarkers of early prostate cancer.

Altintas DM, Allioli N, Decaussin M, de Bernard S, Ruffion A, Samarut J, Vlaeminck-Guillem V.

PLoS One. 2013 Jun 28;8(6):e66278. doi: 10.1371/journal.pone.0066278. Print 2013.

PMID:
23840433
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Effects of the antiandrogen flutamide on the expression of protein kinase C isoenzymes in LNCaP and PC3 human prostate cancer cells.

Montalvo L, Carmena MJ, Bolaños O, Rodríguez-Henche N, Sánchez-Chapado M, Prieto JC.

Biosci Rep. 2004 Feb;24(1):11-21.

PMID:
15499829
[PubMed - indexed for MEDLINE]
Free Article
17.

Expression changes and regulation of AR and IGF-1 in PC3 prostate cancer cells treated with sexual hormones and flutamide.

Tong da Y, Wu Xy, Sun Hy, Jin Y, Liu Zw, Zhou Fj.

Tumour Biol. 2012 Dec;33(6):2151-8. doi: 10.1007/s13277-012-0475-3. Epub 2012 Aug 31.

PMID:
22935919
[PubMed - indexed for MEDLINE]
18.

MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta.

Cao P, Deng Z, Wan M, Huang W, Cramer SD, Xu J, Lei M, Sui G.

Mol Cancer. 2010 May 17;9:108. doi: 10.1186/1476-4598-9-108.

PMID:
20478051
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer.

Love HD, Booton SE, Boone BE, Breyer JP, Koyama T, Revelo MP, Shappell SB, Smith JR, Hayward SW.

PLoS One. 2009 Dec 21;4(12):e8384. doi: 10.1371/journal.pone.0008384.

PMID:
20027305
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancer.

Saraon P, Musrap N, Cretu D, Karagiannis GS, Batruch I, Smith C, Drabovich AP, Trudel D, van der Kwast T, Morrissey C, Jarvi KA, Diamandis EP.

J Biol Chem. 2012 Oct 5;287(41):34019-31. doi: 10.1074/jbc.M112.384438. Epub 2012 Aug 20.

PMID:
22908226
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk